Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MEDI5117 |
| Trade Name | |
| Synonyms | MEDI-5117 |
| Drug Descriptions |
MEDI5117 is an anti-IL6 monoclonal antibody, which inhibits IL6 autocrine signaling, potentially leading to decreased tumor cell growth (PMID: 26744529, PMID: 27237319). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cisplatin + Gemcitabine + MEDI5117 | Cisplatin Gemcitabine MEDI5117 | 0 | 0 |
| Docetaxel + MEDI5117 | Docetaxel MEDI5117 | 0 | 0 |
| Doxorubicin + MEDI5117 | Doxorubicin MEDI5117 | 0 | 0 |
| Gefitinib + MEDI5117 | Gefitinib MEDI5117 | 0 | 0 |
| MEDI5117 | MEDI5117 | 0 | 0 |
| MEDI5117 + Paclitaxel | MEDI5117 Paclitaxel | 0 | 0 |
| MEDI5117 + Pemetrexed Disodium | MEDI5117 Pemetrexed Disodium | 0 | 0 |
| MEDI5117 + Topotecan | MEDI5117 Topotecan | 0 | 0 |